A systematic review of the cost-effectiveness of anti-VEGF drugs for the treatment of diabetic retinopathy

Background Non-proliferative and proliferative diabetic retinopathy are common complications of diabetes and a major cause of sight loss. Anti-vascular endothelial growth factor drugs represent a treatment option for people with diabetic retinopathy and are routinely used to treat various other eye...

Full description

Saved in:
Bibliographic Details
Main Authors: Robert Hodgson, Matthew Walton, Helen Fulbright, Laura Bojke, Ruth Walker, Alexis Llewellyn, Sofia Dias, Lesley Stewart, David Steel, John Lawrenson, Tunde Peto, Mark Simmonds
Format: Article
Language:English
Published: NIHR Journals Library 2025-01-01
Series:Health Technology Assessment
Subjects:
Online Access:https://doi.org/10.3310/NHYK3694
Tags: Add Tag
No Tags, Be the first to tag this record!